Expression of MUC15 and PI3K/Akt in gastric carcinoma and its association with clini- copathological characteristics and prognosis
暂无分享,去创建一个
Caixia Cheng | Pengzhou Kong | Yanyan Zhang | Jiansheng Guo | Shujing Li | Jinyao Dong | Ruizhou Rong | Zhiwei Han
[1] Anthony P Corfield,et al. Mucins: a biologically relevant glycan barrier in mucosal protection. , 2015, Biochimica et biophysica acta.
[2] N. Yoo,et al. Frameshift Mutations of MUC15 Gene in Gastric and its Regional Heterogeneity in Gastric and Colorectal Cancers , 2015, Pathology & Oncology Research.
[3] I. van Seuningen,et al. Mucins and tumor resistance to chemotherapeutic drugs. , 2014, Biochimica et biophysica acta.
[4] Wanqing Chen,et al. Report of cancer incidence and mortality in China, 2010. , 2014, Annals of translational medicine.
[5] Wenbing Yang,et al. Correlations of MUC15 overexpression with clinicopathological features and prognosis of glioma , 2014, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[6] D. Park,et al. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer , 2014, International journal of cancer.
[7] Hong-Yang Wang,et al. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. , 2013, Gastroenterology.
[8] Liang Zhou,et al. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. , 2013, International journal of oncology.
[9] H. Engin,et al. Chemotherapy in elderly patients with metastatic gastric cancer; a single Turkish cancer center experience. , 2013, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.
[10] H. Engin,et al. P-0085CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER; A SINGLE TURKISH CANCER CENTER EXPERIENCE , 2013 .
[11] I. van Seuningen,et al. Membrane-bound mucin modular domains: from structure to function. , 2013, Biochimie.
[12] Min Li,et al. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway , 2013, Molecular and Cellular Biochemistry.
[13] A. Paradiso,et al. Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors. , 2012, Current pharmaceutical design.
[14] B. Li,et al. Upregulation of periostin prevents P53-mediated apoptosis in SGC-7901 gastric cancer cells , 2012, Molecular Biology Reports.
[15] D. Takai,et al. Analysis for the combination expression of CK20, FABP1 and MUC2 is sensitive for the prediction of peritoneal recurrence in gastric cancer. , 2012, Japanese journal of clinical oncology.
[16] W. Chung,et al. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.
[17] F. Hsieh,et al. Mucin 15 is expressed in human placenta and suppresses invasion of trophoblast-like cells in vitro. , 2007, Human reproduction.
[18] V. Dangles-Marie,et al. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. , 2006, Human reproduction update.
[19] H. Kuwano,et al. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. , 2006, European Journal of Cancer.
[20] Z. Hui. Study of MEK2/ERK signal transduction pathway in the colorectal cancer , 2004 .
[21] L. K. Rasmussen,et al. Isolation and characterization of MUC15, a novel cell membrane-associated mucin. , 2002, European journal of biochemistry.